This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Audiences:
Pharmacists
Publication Date:
2016
Format:
Report
52 pages
Last Updated Date:
Publication ID:
36457